(Q37852466)

24 August 2017

1 reference

title

Antibiotic dosing in critical illness (English)

1 reference

24 August 2017

Cathrine McKenzie

1

1 reference

PubMed ID

21398304

24 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Journal of Antimicrobial Chemotherapy

24 August 2017

1 reference

24 August 2017

66 Suppl 2

1 reference

24 August 2017

ii25-31

1 reference

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Dosing of medications in morbidly obese patients in the intensive care unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Clinical pharmacokinetics of drugs in obesity. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Effect of obesity on the pharmacokinetics of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

What is the evidence for once-daily aminoglycoside therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

New pharmacodynamic parameters for antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Pharmacokinetics of inhaled colistin in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Continuous infusion of beta-lactams in the intensive care unit--best way to hit the target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Molecular mechanisms of drug metabolism in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Optimizing use of aminoglycosides in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Using pulse pressure variation or stroke volume variation to diagnose right ventricular failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

Why monitor peak vancomycin concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ516

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ516

1 reference

24 August 2017

1 reference

PubMed ID

21398304